SPY412.27-3.80 -0.91%
DIA338.12-3.18 -0.93%
IXIC13,818.41-131.81 -0.94%

UPDATE: Catalent Says Will Accelerate Qualification, Scale-Up Of Added High-Speed Vial-Filling Line, Expected To Be Operational In Q4'21, Expanded Deal Will Support Production Of J&J's Janssen Vaccine Through Late 2022

-Reuters

· 03/17/2021 09:14